Our highly experienced scientists can readily help you in selecting and controlling the solid state of your API.
Nuvisan offers polymorphism studies to optimise the solid-state properties of your APIs and formulations. Our expertise helps ensure the identification, characterisation and control of polymorphic forms to enhance drug stability, solubility and bioavailability.
Nuvisan’s polymorphism expertise helps ensure robust and efficient development and achieve optimal product performance and regulatory success.
Nuvisan provides tailored salt screening studies to identify and optimise the most suitable salt form of your APIs. Our expertise helps ensure improved solubility, stability and manufacturability, to drive successful drug development.
At Nuvisan, we combine scientific expertise with state-of-the-art technologies to deliver high-quality salt screening services, helping ensure your API achieves its full therapeutic potential.
Nuvisan specialises in X-ray powder diffraction (XRPD) analysis, offering precise insights into the crystalline structure of pharmaceutical compounds. Our XRPD services are essential for understanding material properties, ensuring quality and supporting regulatory requirements.
We provide:
Leveraging our two advanced XRPD instruments, including a GMP-qualified system, and our experienced team, Nuvisan helps ensure reliable, high-quality results to drive your development projects forward.